Depressive symptom is the prevailing non-motor symptom of Parkinson's disease (PD). Drug
treatments for depressed PD (dPD) can mitigate the symptoms of patients. However, the …

Several lines of evidence have strongly implicated neuroinflammation in Parkinson's
disease (PD) progression and l-dopa-induced dyskinesia. The present study investigated …

Parkinson's Disease (PD) is a neurodegenerative disorder characterized by motor
symptoms that result from loss of nigrostriatal dopamine (DA) cells. While L-DOPA provides …

Abstract Although serotonin 1A (5-HT1A) receptor agonists are widely used as the additive
compound to reduce l-dopa-induced dyskinesia in Parkinson's disease (PD), few studies …

Introduction The leading treatment for motor signs of Parkinson's disease is L-DOPA, but,
upon extended use, it can lead to levodopa-induced dyskinesia (LID). Serotonergic neurons …

Background: Parkinson's disease (PD) is a chronic neurodegenerative disorder
characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathway …

Background: The gold-standard treatment for Parkinson's disease is L-DOPA, which in the
long term often leads to levodopa-induced dyskinesia. Serotonergic neurons are partially …

Background Although selective serotonin reuptake inhibitors (SSRIs) are usually considered
safe to use in patients with Parkinson's disease (PD), there are mixed data about their …

Introducción: La discinesia representa la complicación motora más común de la
farmacoterapia con levodopa. La mayoría de los pacientes con Parkinson tienden a …

Abstract Background: L-dopa (Levodopa) is well known for managing PD (Parkinson's
disease); however, its prolonged use caused dyskinesia (LID). Due to the varied …